-Search query
-Search result
Showing 1 - 50 of 832 items for (author: han & sw)

EMDB-43738:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament bound to compound, TDI-2804 (consensus map).
Method: single particle / : Malone BF, Zimmerman JL, Dow LE, Hite RK

EMDB-43739:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament bound to compound, TDI-2804 (focused refinement map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

EMDB-43740:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament bound to compound, XAV (consensus map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

EMDB-43741:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament bound to compound, XAV (focused refinement map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

EMDB-43758:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament - apo state (focused refinement map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

EMDB-43759:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament -apo state (consensus map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

PDB-8w23:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament bound to compound, TDI-2804 (consensus map).
Method: single particle / : Malone BF, Zimmerman JL, Dow LE, Hite RK

PDB-8w25:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament bound to compound, TDI-2804 (focused refinement map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

PDB-8w27:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament bound to compound, XAV (consensus map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

PDB-8w28:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament bound to compound, XAV (focused refinement map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

PDB-8w2t:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament - apo state (focused refinement map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

PDB-8w2u:
Cryo-EM structure of human tankyrase 2 SAM-PARP filament -apo state (consensus map).
Method: helical / : Malone BF, Zimmerman JL, Dow LE, Hite RK

EMDB-70530:
Tetrameric full-length HIV-1 integrase protein complex
Method: single particle / : Jing T, Lyumkis D, Shan Z

EMDB-44962:
Tetrameric Complex of full-length HIV-1 integrase protein bound to the integrase binding domain of LEDGF/p75
Method: single particle / : Jing T, Shan Z, Lyumkis D, Biswas A

EMDB-45103:
Consensus map of NL4-3 WT HIV-1 intasome
Method: single particle / : Lyumkis D, Jing T, Zhang Z

EMDB-45104:
Top half of NL4-3 WT HIV-1 intasome
Method: single particle / : Lyumkis D, Jing T, Zhang Z

EMDB-45150:
Bottom half of NL4-3 WT HIV-1 intasome
Method: single particle / : Lyumkis D, Jing T, Zhang Z

EMDB-45151:
Hexadecamer of NL4-3 WT HIV-1 intasome
Method: single particle / : Lyumkis D, Jing T, Zhang Z, Biswas A

PDB-9bw9:
Tetrameric Complex of full-length HIV-1 integrase protein bound to the integrase binding domain of LEDGF/p75
Method: single particle / : Jing T, Shan Z, Lyumkis D, Biswas A

EMDB-48575:
G002-293-0536 Fab in complex with 001428_T278M_L14 SOSIP and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48591:
G002-480-0546 Fab in complex with V703-0537_T278M_L14 SOSIP and BG18 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9msd:
G002-293-0536 Fab in complex with 001428_T278M_L14 SOSIP and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9msy:
G002-480-0546 Fab in complex with V703-0537_T278M_L14 SOSIP and BG18 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-44925:
Structure of the LM189-Bound beta2AR-Gi Complex
Method: single particle / : Casiraghi M, Wang H, Kobilka BK

PDB-9buy:
Structure of the LM189-Bound beta2AR-Gi Complex
Method: single particle / : Casiraghi M, Wang H, Kobilka BK

EMDB-48283:
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48286:
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48287:
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48290:
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48291:
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-70490:
BG505 GT1.1 SOSIP in complex with gp41-base epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70491:
BG505 GT1.1 SOSIP in complex with V1V2V3 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70492:
BG505 GT1.1 SOSIP in complex with C3V5 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70493:
BG505 GT1.1 SOSIP in complex with CD4bs epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70494:
BG505 GT1.1 SOSIP in complex with gp41 glycan hole epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70495:
BG505 GT1.1 SOSIP in complex with gp41 fusion peptide epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

PDB-9mi0:
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mia:
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mib:
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mih:
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mii:
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-49752:
Consensus refinement for the Uromodulin filament lattice interface
Method: single particle / : Chang AN, Fitzpatrick AWP

EMDB-49792:
Uromodulin filament lattice interface from human urine
Method: single particle / : Chang AN, Fitzpatrick AWP

EMDB-49793:
Uromodulin filament lattice in the straight arrangement from human urine
Method: helical / : Chang AN, Fitzpatrick AWP

EMDB-49794:
Uromodulin filament lattice in the kinked arrangement from human urine
Method: single particle / : Chang AN, Fitzpatrick AWP

PDB-9nu1:
Uromodulin filament lattice interface from human urine
Method: single particle / : Chang AN, Fitzpatrick AWP

PDB-9nu2:
Uromodulin filament lattice in the straight arrangement from human urine
Method: helical / : Chang AN, Fitzpatrick AWP

PDB-9nu3:
Uromodulin filament lattice in the kinked arrangement from human urine
Method: single particle / : Chang AN, Fitzpatrick AWP

EMDB-51378:
Structure of the human mitochondrial pyruvate carrier inhibited by a UK5099-derivative
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, Sowton AP, King MS, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IMF, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS

EMDB-51379:
Structure of the human mitochondrial pyruvate carrier inhibited by zaprinast
Method: single particle / : Sichrovsky M, Lacabanne D, Ruprecht JJ, Rana JJ, Stanik K, Dionysopoulou M, Sowton AP, King MS, Jones S, Cooper L, Hardwick SW, Paris G, Chirgadze DY, Ding S, Fearnley IM, Palmer S, Pardon E, Steyaert J, Leone V, Forrest LR, Tavoulari S, Kunji ERS
Pages: